Fundraising Fox

Trivascular

Santa Rosa, US · Delaware corporation · 2 known investors

trivascular.com ↗

Endologix develops medical devices for treating vascular disease, including the DETOUR™ System for endovascular aortic repair (EVAR) procedures. The company also offers virtual reality-based procedural training for physicians.

HealthtechMedical Devicesin /endologix@Endologix

Founders & leadership

DA
DOUGLAS A. ROEDERDirector
SL
SHARI L. O'QUINNExecutive Officer
MV
MICHAEL V. CHOBOTOVExecutive Officer
MR
MICHAEL R. KRAMERExecutive Officer
RD
RYAN D. DRANTDirector
DJ
DANIEL J. MOOREDirector
KE
KIMBERLEY ELTINGExecutive Officer
CC
CHRISTOPHER CHAVEZExecutive Officer, Director
RW
ROBERT W. THOMASDirector
VK
VIVEK K. JAYARAMANExecutive Officer
JP
JAMES P. SCOPADirector
JR
JAKE R. NUNNDirector

Investors · 2

Kaiser Permanente VenturesSan Francisco · $2M – $5M
SR One Capital ManagementreportedRedwood Cityvia Jake Nunn · board

Reported raises · per SEC filings

Form D private placements
▶$10MraisedAug 2015 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • DOUGLAS A. ROEDERDirector
  • SHARI L. O'QUINNExecutive Officer
  • MICHAEL V. CHOBOTOVExecutive Officer
  • MICHAEL R. KRAMERExecutive Officer
  • RYAN D. DRANTDirector
  • DANIEL J. MOOREDirector
  • KIMBERLEY ELTINGExecutive Officer
  • CHRISTOPHER CHAVEZExecutive Officer, Director
  • ROBERT W. THOMASDirector
  • VIVEK K. JAYARAMANExecutive Officer
  • JAMES P. SCOPADirector
  • JAKE R. NUNNDirector
Offering amount
$10M
Amount sold
$10M
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news